Mesalazine-induced Pleuropericarditis in a Patient with Crohn's Disease
Hidemichi Kiyomatsu1, Kazushige Kawai, Toshiaki Tanaka
1Department of Surgical Oncology, Faculty of Medicine, The University of Tokyo, Japan.
Abstract:
A 16-year-old boy was diagnosed with Crohn's disease. Treatment with oral mesalazine was started at 3 g per day; however, he complained of high fever, a nonproductive cough, and left shoulder pain after 2 weeks. His chest radiography and chest computed tomography showed cardiomegaly and left pleural effusion, while an echocardiogram revealed pericardial effusion. Because no infection was detected by thoracentesis and the drug lymphocyte stimulation tests for mesalazine were positive, the patient was diagnosed with mesalazine-induced pleuropericarditis. After the cessation of mesalazine, the clinical symptoms and laboratory findings quickly improved.
Related Concept Videos
Pericarditis II: Clinical Features and Diagnostic Tests
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Pericarditis IV: Nursing Management
Pericarditis III: Medical Management
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Pericarditis I: Introduction

